Article thumbnail

Translocation pathways for inhaled asbestos fibers

By G Miserocchi, G Sancini, F Mantegazza and Gerolamo Chiappino

Abstract

We discuss the translocation of inhaled asbestos fibers based on pulmonary and pleuro-pulmonary interstitial fluid dynamics. Fibers can pass the alveolar barrier and reach the lung interstitium via the paracellular route down a mass water flow due to combined osmotic (active Na+ absorption) and hydraulic (interstitial pressure is subatmospheric) pressure gradient. Fibers can be dragged from the lung interstitium by pulmonary lymph flow (primary translocation) wherefrom they can reach the blood stream and subsequently distribute to the whole body (secondary translocation). Primary translocation across the visceral pleura and towards pulmonary capillaries may also occur if the asbestos-induced lung inflammation increases pulmonary interstitial pressure so as to reverse the trans-mesothelial and trans-endothelial pressure gradients. Secondary translocation to the pleural space may occur via the physiological route of pleural fluid formation across the parietal pleura; fibers accumulation in parietal pleura stomata (black spots) reflects the role of parietal lymphatics in draining pleural fluid. Asbestos fibers are found in all organs of subjects either occupationally exposed or not exposed to asbestos. Fibers concentration correlates with specific conditions of interstitial fluid dynamics, in line with the notion that in all organs microvascular filtration occurs from capillaries to the extravascular spaces. Concentration is high in the kidney (reflecting high perfusion pressure and flow) and in the liver (reflecting high microvascular permeability) while it is relatively low in the brain (due to low permeability of blood-brain barrier). Ultrafine fibers (length < 5 μm, diameter < 0.25 μm) can travel larger distances due to low steric hindrance (in mesothelioma about 90% of fibers are ultrafine). Fibers translocation is a slow process developing over decades of life: it is aided by high biopersistence, by inflammation-induced increase in permeability, by low steric hindrance and by fibers motion pattern at low Reynolds numbers; it is hindered by fibrosis that increases interstitial flow resistances

Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2265277
Provided by: PubMed Central

Suggested articles

Citations

  1. (1988). A: Alveolar fiber load in asbestos workers and in subjects with no occupational asbestos exposure.
  2. (1981). A: Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals.
  3. Anatomy of the blood and lymphatic circulation of the pleural serosa.
  4. (1998). Anatomy of the pleura. Clin Chest Med
  5. (1987). AR: Clearance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ Res
  6. (1980). Bertazzi PA: The value of nonradiological indicators in the early diagnosis of asbestosis.
  7. (2006). Biochemical and morphological changes in endothelial cells inresponse to hypoxic interstitial edema. Respir Res
  8. (2007). BT: Airway epithelial NF-kB activation modulates asbestosinduced inflammation and mucin production in vivo.
  9. (2005). BT: Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res
  10. (1991). C: A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques.
  11. (2003). Cell signaling and transcription factor activation by asbestos in lung injury and disease.
  12. (1999). Cellular and molecular mechanisms of asbestos-induced fibrosis.
  13. (1985). Clearance from the respiratory tract. Fundam Appl Toxicol
  14. (2002). Composition, biophysical properties and morphometry of plasma membranes in pulmonary interstitial edema.
  15. (1994). Correlation between particle size, in vivo particle persistence and lung injury. Environ Health Perspect
  16. (1986). Crapo JD: Airway branching patterns influence asbestos fiber location and the extent of tissue injury in the pulmonary parenchyma. Lab Invest
  17. (1996). De Vuyst P: Blackspots concentrate oncogenic asbestos fibers in the parietal pleura.
  18. (2001). Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sc
  19. (1991). Distribution of diaphragmatic lymphatic stomata.
  20. (1984). DN: Exchange of macromolecules across the microcirculation. In Handbook of Physiology: The Cardiovascular System. Microcirculation Volume VI. American Physiological Society.
  21. (1997). E: Pleural macrophage recruitment and activation in asbestosinduced pleural injury. Environ Health Perspect
  22. (1997). Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies. Environ Health Perspect
  23. (1980). EC: Presence of asbestos bodies in organs other than the lung. Chest
  24. (1993). Fabbro M: Model of pleural fluid turnover.
  25. (2003). G: Compositional changes in lipid microdomains of ABB plasma membranes in pulmonary interstitial edema.
  26. (2003). Gene expression analysis in interstitial lung edema induced by saline infusion. Bioch Bioph Acta-Mol Basis of Dis
  27. (2002). Ghigo D: Crocidolite asbestos inhibits pentose phosphate oxidative pathway and glucose-6-phosphate dehydrogenase activity in human lung epithelial cells. Free Radic Biol Med
  28. (1986). Giuntini C: Kinetics of the intrapleural distribution of a radioactive bolus. Respir Physiol
  29. (1990). Gonano C: Direct measurements of interstitial pulmonary pressure in-in situ lung with intact pleural space.
  30. (1992). Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant.
  31. (2000). Hammar SP: Asbestos in extrapulmonary sites* Omentum and Mesentery. Chest
  32. (2000). Hors N: Pathways and quantification of insoluble particles in the lung compartment of the rat.
  33. (1992). Intrapleural fluid movements described by a porous flow model.
  34. (1991). Kohyama N: Translocation of inhaled asbestos fibers from the lung to other tissues.
  35. (1989). Lung cell reactionsin guinea pigs after inhalation of asbestos (amosite). Toxicology
  36. (1997). Mineral analysis of the lung parenchyma. In The Lung: Scientific Foundations Volume 2. 2nd edition. Edited by: Crystal RG,
  37. (1993). Mineral fibers: correlation between the oxidizing surface activity and the DNA base hydroxylation.
  38. (2004). Miserocchi G: Endothelial cells as early sensors of pulmonary interstitial edema.
  39. (1998). Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity.
  40. (2006). Negrini D: Functional arrangement of the rat diaphragmatic initial lymphatic network. Am J Physiol Heart Circ Physiol
  41. (1987). Ohnishi Y: A quantitative study on the distribution of asbestos bodies in extrapulmonary organs. Acta Pathol Jpn
  42. (2006). Oury TD: Matrix metalloproteinases promote inflammation and lung injury in mice.
  43. (2004). Oury TD: Redistribution of pulmonary EC-SOD exposure to asbestos.
  44. (1989). Pezerat H: Thermodynamic aspects in the adsorption of polynuclear aromatic hydrocarbons on chrysotile and silica-possible relation to synergistic effects in lung toxicity.
  45. Pleural space: pressures and fluid dynamics.
  46. (2000). Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappa B. Free Radical Biology and Medicine
  47. (2004). Sahn SA: Causes and management of pleural fibrosis. Respirology
  48. (2005). Short thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence.
  49. (2002). SR: Asbestos fibers contributing to the induction of human malignant mesothelioma.
  50. (1997). Surface reactivity in the pathogenic response to particulates. Environ Health Perspect
  51. (1988). Takeuchi Y: Asbestos fibers in human pulmonary and extrapulmonary tissues.
  52. (2004). Tanaka I: Patterns of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhal Toxicol
  53. (2003). The biopersistence of canadian chrysotile asbestos following inhalation. Inhal Toxicol
  54. (2003). Ultrastructure and three-dimensional study of the lymphatic stomata in the costal pleura of rabbit. Micros Res tech
  55. (2000). VC: Pahogocitosis of crocidolite asbestos induces oxidative stress, DNA damage and apoptosis in mesothelial cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.